Stay updated with breaking news from Formation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Veolia (VE) announced Tuesday that its consulting engineering and strategic and operational assistance division Seureca announced the acquisition of MRC Consultants and Transaction Advisers.
American Strategic Investment Co. (NYC) has filed with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9 and letter to stockholders, regarding the tender offer commenced by Bellevue Capital Partners, on May 7, 2024, to purchase up to 125,000 shares of the company's Class A common stock at a price of $9.
The Ukraine Defense Contact Group has vowed that it remains laser-focused on arming Ukraine with critical capabilities as Russia attempts to capture new ground in Ukraine's northeast near Kharkiv.
Halozyme Therapeutics, Inc. (HALO) said Bristol Myers Squibb was reassigned a Prescription Drug User Fee Act goal date from the FDA for their Biologics License Application for the subcutaneous formulation of Opdivo co-formulated with ENHANZE, Halozyme's recombinant human hyaluronidase enzyme, rHuPH20, across all previously approved adult, solid tumor Opdivo indications as monotherapy, monotherapy maintenance following completion of Opdivo plus Yervoy combination therapy, or in combination with chemotherapy or cabozantinib.
French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing drugs...